國立虎尾科技大學 |

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry/ by Mithun Nandy.
作者:	Nandy, Mithun.
面頁冊數:	XXXI, 202 p. 25 illus., 20 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Asian Economics. -
電子資源:	https://doi.org/10.1007/978-981-16-6921-7
ISBN:	9789811669217

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
Nandy, Mithun.

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry[electronic resource] /by Mithun Nandy. - 1st ed. 2022. - XXXI, 202 p. 25 illus., 20 illus. in color.online resource.

Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.

The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View. .

ISBN: 9789811669217

Standard No.: 10.1007/978-981-16-6921-7doiSubjects--Topical Terms:

1107724
Asian Economics.

LC Class. No.: HD2321-4730.9

Dewey Class. No.: 338

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
LDR:03590nam a22003855i 4500 001 1091493
003 DE-He213
005 20220502123153.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811669217 $9 978-981-16-6921-7
024 7 $a 10.1007/978-981-16-6921-7 $2 doi
035 $a 978-981-16-6921-7
050 4 $a HD2321-4730.9
072 7 $a KN $2 bicssc
072 7 $a BUS000000 $2 bisacsh
072 7 $a KN $2 thema
082 0 4 $a 338 $2 23
100 1 $a Nandy, Mithun. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1399088
245 1 0 $a Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry $h [electronic resource] / $c by Mithun Nandy.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Palgrave Macmillan, $c 2022.
300 $a XXXI, 202 p. 25 illus., 20 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.
520 $a The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View. .
650 2 4 $a Asian Economics. $3 1107724
650 2 4 $a Asian Business. $3 1141614
650 2 4 $a Market Research and Competitive Intelligence. $3 1388172
650 2 4 $a Financial Reporting. $3 1366480
650 1 4 $a Sector and Industry Studies. $3 1388439
650 0 $a Asia—Economic conditions. $3 1253468
650 0 $a Asia. $3 934947
650 0 $a Business. $3 558617
650 0 $a Business intelligence. $3 557121
650 0 $a Marketing research. $3 561150
650 0 $a Financial statements. $3 560840
650 0 $a Industries. $3 684170
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811669200
776 0 8 $i Printed edition: $z 9789811669224
856 4 0 $u https://doi.org/10.1007/978-981-16-6921-7
912 $a ZDB-2-ECF
912 $a ZDB-2-SXEF
950 $a Economics and Finance (SpringerNature-41170)
950 $a Economics and Finance (R0) (SpringerNature-43720)